New tool improves risk assessment for age-related macular degeneration
A new tool covering baseline retinal characteristics improves risk assessment for age-related macular degeneration, according to a report in the Archives of Ophthalmology.
British researchers say that embryonic stem cell therapy could cure age-related macular degeneration, a common form of blindness.